Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | CPI-0610 |
Trade Name | |
Synonyms | CPI0610|pelabresib |
Drug Descriptions |
CPI-0610 is a small molecule that binds to BET bromodomains and inhibits interaction with acetylated histones, resulting in regulation of BET-dependent gene expression and anti-tumor effects (PMID: 26815195, PMID: 31729905). |
DrugClasses | BET Inhibitor (Pan) 32 |
CAS Registry Number | 1380087-89-7 |
NCIT ID | C111901 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
CPI-0610 | CPI-0610 | 0 | 4 |
CPI-0610 + Dasatinib | CPI-0610 Dasatinib | 0 | 0 |
CPI-0610 + Dasatinib + Rucaparib | CPI-0610 Dasatinib Rucaparib | 0 | 0 |
CPI-0610 + Doxorubicin | CPI-0610 Doxorubicin | 0 | 0 |
CPI-0610 + Rucaparib | CPI-0610 Rucaparib | 0 | 0 |
CPI-0610 + Ruxolitinib | CPI-0610 Ruxolitinib | 0 | 2 |